Possible new immunosuppressants through biosynthesis: Derivatives of the immunosuppressant rapamycin, such as analogue 3, are obtained by feeding simple carboxylic acids to the rapamycin-producing organism. Incorporation of these alternative starter units appears to be preceded by their specific hydroxylation.
No takes yet. Share an insight, caveat, or question.
Lowden et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: